![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Saving time in the radiotherapy procedures for COVID-19 pneumonia treatment. A single-institution experience
The use of low dose radiotherapy (LD-RT) for the treatment of COVID-19 pneumonia is supported by biological rationale for its immunomodulatory effect. Some institutions have started to treat these patients sho...
-
Article
Low-dose radiation therapy: could it be a game-changer for COVID-19?
-
Article
Radiotherapy is safe in patients with implantable cardiac devices. Analysis of a systematic interrogation follow-up
The number of patients who have a cardiac implantable electronic device (CIEDs) that undergo a course of radiotherapy is increasing due to the ageing population. The majority of clinical studies only evaluate ...
-
Article
Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma?
To determine whether brachytherapy with a single hypofractionated dose of 7 Gy provides the similar vaginal-cuff relapses and safety profile in terms of complications compared to schedules of 2 or 3 fractions ...
-
Article
Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy
Neoadjuvant chemotherapy (NACT) is employed in patients with breast cancer (BC) with the aim of reducing tumor burden and improving surgical outcomes. We evaluated the levels of energy metabolites pre- and pos...
-
Article
Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients
To evaluate the effect of boost radiotherapy on ipsilateral breast tumor recurrence (IBTR) for ductal carcinoma in situ (DCIS) after breast-conserving surgery and whole breast radiotherapy (WBRT) with or witho...
-
Article
Are there enough radiation oncologists to lead the new Spanish radiotherapy?
Radiation oncology services in Spain are undergoing a process of technical modernization, but—in a context of increasing demand by an ageing population—it is unclear whether there are enough radiation oncologi...
-
Article
Management of patients with implanted cardiac devices during radiotherapy: results of a Spanish survey in radiation oncology departments
There is an increasing number of patients with cardiac implantable electronic devices (CIED), either pacemakers or defibrillators, who are receiving a course of radiotherapy. Several guidelines have been publ...
-
Article
Are endometrial cancer radiotherapy results age related?
To analyze the impact of age on radiotherapy results based on cancer-specific survival (CSS), vaginal-cuff relapses (VCR) and complications analysis in 438 patients with endometrial carcinoma (EC) receiving po...
-
Article
Correction to: Curative radiation therapy for very elderly bladder cancer patients with localized disease
In the original version of this article the figure captions of Figs. 1 and 2 were interchanged.
-
Article
Curative radiation therapy for very elderly bladder cancer patients with localized disease
To report the outcomes of a cohort of very elderly muscle-invasive bladder cancer (MIBC) patients treated with contemporary 3D-conformal radiation therapy (3D-CRT) with or without concurrent chemotherapy, afte...
-
Article
Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy
Clinical indications of brachytherapy in non-melanoma skin cancers, description of applicators and dosimetry recommendations are described based on the literature review, clinical practice and experience of S...
-
Article
Exploring Institutional Mechanisms for Scientific Input into the Management Cycle of the National Protected Area Network of Peru: Gaps and Opportunities
Understanding how to improve decision makers’ use of scientific information across their different scales of management is a core challenge for narrowing the gap between science and conservation practice. Here...
-
Article
Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients
To analyze the vaginal-cuff local control (VCC) and toxicity in postoperative endometrial carcinoma patients (EC) underwent high-dose-rate brachytherapy (HDR-BT) administered daily.
-
Article
The position and current status of radiation therapy after primary systemic therapy in breast cancer: a national survey-based expert consensus statement
Primary systemic therapy (PST) is changing the role of radiation therapy (RT) in breast cancer. Without randomized studies, the optimal indications for RT after PST and surgery are not clear. The present study...
-
Article
Genetic consequences of habitat fragmentation during a range expansion
We investigate the effect of habitat fragmentation on the genetic diversity of a species experiencing a range expansion. These two evolutionary processes have not been studied yet, at the same time, owing to t...
-
Article
Coestimation of recombination, substitution and molecular adaptation rates by approximate Bayesian computation
The estimation of parameters in molecular evolution may be biased when some processes are not considered. For example, the estimation of selection at the molecular level using codon-substitution models can hav...
-
Article
Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapy
The goal of this work was to evaluate whether the volume reduction related to removal of gas in the rectum could be translated in lower doses to organs at risk (OAR) during vaginal cuff brachytherapy (VBT).
-
Article
Consensus on the regional lymph nodes irradiation in breast cancer
Standard locoregional treatment of early-stage breast cancer currently consists of the conservative surgery and sentinel lymph node biopsy. In the event of positive sentinel node biopsy, an axillary level I–II...
-
Article
Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity
High-dose-rate brachytherapy (HDR-BT) is an accepted part of treatment for endometrial carcinoma and is usually performed in 1–2 fractions per week using different total doses and doses per fraction. To reduce...